We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Neuropharm | LSE:NPH | London | Ordinary Share | GB00B1NPJJ01 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.50 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
29/9/2009 10:50 | Vince - you been on those pills again? | lombiff | |
29/9/2009 10:47 | Men in short skirts come bearing a golden eagle standard and Pizzas.... must be friendly then. | luckyvince | |
29/9/2009 10:42 | Nothing wrong with runes, they were good enough for the druids. | luckyvince | |
29/9/2009 10:42 | LOL well with a name like Tadpole Technology there was always a chance of croaking it?? Crystal balls are probably the best way to judge the market I did sell a cow to a man for 3 beans and when I planted them I got some nice runner beans seemed I was scammed on that occasion | quinan | |
29/9/2009 10:15 | Q - never tried one - that is sophisticated - do they cost much to run? I did buy a million shares in Tadpole Technology about ten years ago, after consulting the runes, and I lost 95% of my investment - I won't use them again. | lombiff | |
29/9/2009 10:06 | Well I am a little more sophisticated I brought a crystal ball form a Gypsy at a travailing fair, it works quite well but I do have to look into it very hard sometimes? | quinan | |
29/9/2009 10:03 | Q - yes, I can see £1-£1.20 within a year, but I think £2 is down the road a bit, and depends on a successful trial for 2008, and some good news on one of the other compounds. My calculations are all based on the proven finger-in-the-air method, backed up by tea-leaves. btw, just bought another 10K on the dip - anyone else topping up? | lombiff | |
29/9/2009 09:50 | Looks to me like that was a good old shake by the MM's if we get a bit more buying then this will quickly turn. Lom I was looking for £1-£1.20p but £2 would do??? | quinan | |
29/9/2009 09:25 | Quinan/Arc - on a fresh trial backed by a big pharma, I see no reason why this wouldn't be in the 50-80p range (50% discount to where we were before February, and to Edison's valuation based on 20% success for 2008). After a successful trial, and taking it to market, who knows, but I suspect we may be taken out by the JV partner before then. I hope not, unless it's well north of £2. I don't think I'll be able to resist a top-slice if we get close to £1, but I'd like to think I'll keep a good core holding for a few years. Does anyone know if the EMMA trial (long-term trial of 2008, with results expected in H2 2010) is still ongoing, or if it was shelved after SOFIA was inconclusive? | lombiff | |
29/9/2009 09:22 | Bit of a turn around - nerves perhaps. | luckyvince | |
29/9/2009 08:52 | Exactly right. The interest of what NPH have called a "much larger" pharma will indicate just how close we are to getting this to market, and therefore far easier for a bigger company to come in with us now than it would be to develop their own compound at this stage. We know that the company was always being courted by the big boys and have even had disclosed approaches. This drug is badly needed and everyone will be working hard to get this approved and out there. | arc2006 | |
29/9/2009 08:51 | Mike...You got me going then, until I saw the Monday bit. Price then about 160p. I hope none of you hold from that level. GLA. | the_beagle | |
29/9/2009 08:45 | Lom it depends of what you call full value? What do we put on their compounds what other products do they have in the pipe line? What input will the JV have? As far as I can see there is no other company who offers what NPH intend to offer hence all the interest form others. Any way we should get some sort of idea as to what they intend to do in tomorrows results. Like you I would be very surprised if we get the JV news tomorrow more like an indication as to when things might be signed, also I would hope to get a little more news on NPL2003 and 2005 if all seem to be on track then I think we should be looking at 45p + then I recon the JV might be announced late October ???? | quinan | |
29/9/2009 08:36 | kiki . . snap! | lombiff | |
29/9/2009 08:36 | Mike - that's last year's news - Monday 29th, talking about results in Q209 etc etc. It will be interesting to see tomorrow's results, but I still think it will take a couple of years to get full value (with compounds being distributed for autism, OCD and fragile X) - patience required, and not just for a few months. As my kids keep telling me, take a chill pill! | lombiff | |
29/9/2009 08:35 | Mike_F...last years news! shame | kiki14p | |
29/9/2009 08:27 | Just found this: | mike_f | |
29/9/2009 08:14 | QUIN, i'd say so... lol | mike_f | |
29/9/2009 07:50 | Looks like it's a BUY then | quinan | |
29/9/2009 07:36 | Check out Barchart this morning: | mike_f | |
29/9/2009 07:24 | Seems we're off and away again and they're lifting the bid to get our shares. Hold on guys. | arc2006 | |
29/9/2009 07:09 | Bit of volatility to shake the weak holders into taking a little profit ? | ihavenoclue | |
29/9/2009 07:09 | Boobly ... for some reason I have a figure of about £1.20 in mind, so 41p short of your target. | ihavenoclue |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions